Information for the public, researchers, academics and clinicians on COVID-19 research taking place on the Cambridge Biomedical Campus.
A partnership, funded and supported by the NIHR, between Cambridge University Hospitals and the University of Cambridge to deliver ground-breaking research that benefits patients.
Covering 15 different health themes and supported by world-leading experts, our research helps deliver better medicines and treatments for the NHS. Find out more about the research we support.
Our research is strengthened through collaboration and partnership with industry – from small biotechs to multinational pharmaceuticals. Find out more about our work with industry.
We put patients at the heart of our research. Help us to make sure research meets patients’ needs. There are lots of ways you can get involved – find out more today.
State-of-the-art infrastructure and facilities to support research delivery: all located on a single site just one hour from London. Find out more about the facilities on site.
A device to help treat tumours in the liver has received a £1 million Government grant.Read more
As many as one in 100 patients admitted to hospital with COVID-19 develop a pneumothorax – a ‘punctured lung’ according to a study supported by the NIHR Cambridge BRC. Read more
DNA from tissue biopsies taken from patients with Barrett’s oesophagus – a risk factor for oesophageal cancer – could show which patients are most likely to develop the disease eight years before diagnosis.Read more